Fibrosis D005355

Description

Any pathological condition where fibrous connective tissue invades any organ, usually as a consequence of inflammation or other injury.   MeSH

Hierarchy View

Subtype Terms (5)

Cicatrix
128 drugs (73 approved, 55 experimental)

Liver Cirrhosis
332 drugs (182 approved, 150 experimental)

Nephrogenic Fibrosing Dermopathy
2 drugs (1 approved, 1 experimental)

Peritoneal Fibrosis
1 approved drug

Retroperitoneal Fibrosis
9 drugs (8 approved, 1 experimental)


Phase 4 Indicated Drugs (177)

Key: D005355 (138) Subtype (39)

Phase 3 Indicated Drugs (133)

Key: D005355 (120) Subtype (13)

Phase 2 Indicated Drugs (250)

Key: D005355 (201) Subtype (49)

Phase 1 Indicated Drugs (95)

Key: D005355 (69) Subtype (26)

Other Experimental Indicated Drugs (97)

Key: D005355 (77) Subtype (20)


Organization Involved with Phase 4 Indications (140)

Key: D005355 (108) Subtype (32)

Organization Involved with Phase 3 Indications (141)

Key: D005355 (122) Subtype (19)

Organization Involved with Phase 2 Indications (255)

Key: D005355 (215) Subtype (40)

A2 Healthcare Taiwan Corporation

Advanced Inhalation Therapies Ltd

Afferent Pharmaceuticals

Ain Shams University

Allegro Ophthalmics, LLC

Amarillo Biosciences, Inc.

American Health Research

AOP Orphan Pharmaceuticals AG

Arena Pharmaceuticals

Aridis Pharmaceuticals, Inc.

Asian American Liver Centre

Assiut University

AstraZeneca

Augusta University

Avanti Polar Lipids, Inc.

Avanza Research

AzurRx

Baxalta

Baylor University

Beijing Kawin Technology Share-Holding Co., Ltd.

Beike Biotech

Bellerophon Therapeutics

Ben Gurion University

Bharat Biotech International Limited

Bharti Hospital

Biocad

Biogen

Bio-Images Research Ltd

Biosplice Therapeutics

Blade Therapeutics

Body Aesthetic Plastic Surgery and Skincare Center, St Louis, Missori

Bombay Hospital & Medical Research Center

Breach Candy Hospital, Mumbai

Bristol-Myers Squibb

Capstone Therapeutics

Catholic University of Sacred Heart, Rome

Cedars-Sinai Medical Center

Celgene

Celixir

Celtaxsys, Inc.

Centocor

Centre for Liver Research & Diagnostics, Hyderabad

Chaitanya Hospital

Chinese Academy of Medical Sciences

CJ HealthCare Corp.

Cochin Hospital, India

Conatus Pharmaceuticals

Concert Pharmaceuticals

Corbus Pharmaceuticals Inc.

Corporacion Parc Tauli

Cumballa Hill Hospital And Heart Institute

Cumberland Pharmaceuticals

Dartmouth University

Daw Park Repatriation, Australia

Debiopharm

Department of Defense

Department of Radiation Oncology

Desmond Wai Liver & Gastrointestinal Diseases Centre

Dunedin Public Hospital, New Zealand

EA Pharma Co., Ltd.

Eli Lilly

Eloxx Pharmaceuticals, Inc.

Enanta Pharmaceuticals

Erempharma

Fast Forward Pharmaceuticals

Federal Research Clinical Center of Federal Medical & Biological Agency, Russia

Federal University of Minas Gerais

Flatley Discovery Lab LLC

Fortis Hospitals, India

Galectin Therapeutics Inc.

Galecto Biotech

General Hospital of Chinese Armed Police Forces

Genkyotex Innovation SAS

Ghent University

Global Blood Therapeutics, Inc.

Government of China

Government of Russia

Grupo Mexicano para el Estudios de las Enfermedades Hepaticas

Gwo Xi Stem Cell Applied Technology Co., Ltd.

Hennepin Healthcare

Hopital Paul Brousse

Horizon Pharma

Hospital Sao Rafael

Huazhong University

Hugel

Humanigen

Immunitor LLC

Immunsystem AB

Institut Gustave Roussy

Institut National de la Santé Et de la Recherche Médicale, France

Instituto Nacional de Enfermedades Respiratorias

Into Research, South Africa

ISDIN

Jiangsu Chia-tai Tianqing Pharmaceutical Co.,Ltd

Jinan University

John and Rebecca Moore's Cancer Center

Kadmon

Kamada, Ltd.

Karnataka Institute of Medical Sciences

Karolinska Institute

Kinderklinik und Kinderpoliklinik im Haunerschen Kinderspital

LanZhou University

Laser and Skin Surgery Center of New York

Laurent Pharmaceuticals Inc.

Leading BioSciences, Inc

Legacy Health System

Leiden University

Life Mount Edgecombe Hospital, South Africa

Lung Biotechnology PBC

Mallinckrodt

Maternal and Child Health Hospital of Foshan

McNeil

Medical College of Wisconsin

Medical University of Warsaw

MediciNova

Mediciti Hospital

MedImmune

Melaka Manipal Medical College

Midland Healthcare & Research Center, India

miRagen Therapeutics, Inc.

Moorgreen Hospital, Southampton

Moscow State University

Nanjing Medical University

National Cancer Institute (NCI)

National Heart, Lung, and Blood Institute (NHLBI)

National Human Genome Research Institute (NHGRI)

National Institute of Allergy and Infectious Diseases (NIAID)

National Taiwan University

Newcastle University

NGM Biopharmaceuticals, Inc

Niigata University Medical & Dental Hospital

Nitto Denko Corporation

Nivalis Therapeutics, Inc.

Noorik Biopharmaceuticals AG

Nordmark Arzneimittel GmbH & Co. KG

Northwestern University

NovaBiotics Ltd.

NovImmune SA

Novo Nordisk

Novoteris, LLC

Oakland University

Ocera Therapeutics

Oregon Health and Science University

Orpha Labs

Parion Sciences

Parkway Cancer Centre

P.D. Hinduja Hospital and Medical Research Centre, Mumbai

Pergamum AB

Pfizer

Pinnacle Research Group

Polyphor Ltd.

Promedior, Inc.

ProMetic Life Sciences

ProQR Therapeutics

Protalix

Proteostasis Therapeutics

Pulmocide Ltd

Pulmonix LLC, USA

Qilu Pharmaceutical Co., Ltd.

Qingdao Central Hospital

Queen Elizabeth Hospital NHS Foundation Trust

Queen Victoria Hospital, East Grinstead

Radiance Cosmetology Clinique

Radiation Therapy Oncology Group

Rainbow Baby and Children's Hospital

Rajasthan University of Health Sciences

Rajiv Gandhi University of Health Sciences

Reata Pharmaceuticals, Inc.

Region Skane

Rocket Pharma Limited

Rohto Pharmaceutical Co., Ltd.

Royal Marsden Hospital NHS Trust

Royan Institute

Ruby Hall Clinic, Pune

RXi Pharmaceuticals

Saglik Bilimleri Universitesi

Sahyadri Speciality Hospital

Sanjay Gandhi Postgraduate Institute of Medical Sciences

Santhera

Scarless Laboratories, Inc.

SCF Pharma

SCTI Research Foundation

S-Evans Biosciences Co.,Ltd.

Shanghai Genomics, Inc.

Shiraz University

Shire

Sirnaomics

S.Nijalingappa Institute of Dental Science and Research

SolAeroMed Inc.

Southern California Research Center

Spyryx Biosciences, Inc.

Sri Bala Medical Centre and Hospital, India

Stellenbosch University

Stem Med Pte. Ltd.

Stempeutics Research Pvt Ltd

St. Ivan Rilski's University Hospital

Stony Brook University

Stromedix

SVS Institute of Dental Sciences

Swedish Orphan Biovitrum

Synlogic

Tauranga Hospital, New Zealand

Temple Therapeutics BV

Texas Tech University

The First People's Hospital of Lianyungang

The University of Hong Kong

Timeless Chirurgia Plastyczna-Janusz Jaworowski

Tirgan, Michael H., M.D.

Tokuda Hospital

Tokyo Metropolitan Komagome Hospital

Translate Bio, Inc.

Trevi Therapeutics

Tsinghua University

United States Air Force

United Therapeutics

Université catholique de Louvain

University of Aberdeen

University of Arizona

University of Bordeaux

University of British Columbia

University of Calgary

University of Duesseldorf

University of Edinburgh

University of Florida

University of Geneva

University of Gothenburg

University of Groningen

University of Guadalajara

University of Heidelberg

University of Hull

University of Illinois at Chicago

University of Kansas

University of Las Palmas de Gran Canaria

University of Louisville

University of Maryland

University of Nottingham

University of Otago

University of Palermo

University of Sherbrooke

University of Siena

University of Tuebingen

University of Turin

University of Vermont

University of Verona

University of Western Brittany

University of Zurich

Uppsala University

Vermont Lung Center

Vero Biotech

Verona Pharma plc

Via Christi Regional Medical Center

Vinmec International Hospital

Waikato Hospital

Zhongyuan Union Stem Cell Bio-engineering Corporation

Zydus Discovery DMCC

Organization Involved with Phase 1 Indications (66)

Key: D005355 (40) Subtype (26)

Organization Involved with Other Experimental Indications (50)

Key: D005355 (39) Subtype (11)

Hierarchy Tree View

UMLS Data


YOU AGREE THAT THE INFORMATION PROVIDED ON THIS WEBSITE IS PROVIDED “AS IS”, WITHOUT ANY WARRANTY OF ANY KIND, EXPRESSED OR IMPLIED, INCLUDING WITHOUT LIMITATION WARRANTIES OF MERCHANTABILITY OR FITNESS FOR ANY PARTICULAR PURPOSE, OR NON-INFRINGEMENT OF ANY THIRD-PARTY PATENT, COPYRIGHT, OR ANY OTHER THIRD-PARTY RIGHT. IN NO EVENT SHALL THE CREATORS OF THE WEBSITE OR WASHINGTON UNIVERSITY BE LIABLE FOR ANY DIRECT, INDIRECT, SPECIAL, OR CONSEQUENTIAL DAMAGES ARISING OUT OF OR IN ANY WAY CONNECTED WITH THE WEBSITE, THE USE OF THE WEBSITE, OR THIS AGREEMENT, WHETHER IN BREACH OF CONTRACT, TORT OR OTHERWISE, EVEN IF SUCH PARTY IS ADVISED OF THE POSSIBILITY OF SUCH DAMAGES.